143 related articles for article (PubMed ID: 36719643)
1. The benefit of adopting Microultrasound in the prostate cancer imaging pathway: A lesion-by-lesion analysis: Biopsies prostatiques guidée par micro-échographie, quel bénéfice ? Une analyse lésion par lésion.
Martel P; Rakauskas A; Dagher J; La Rosa S; Meuwly JY; Roth B; Valerio M
Prog Urol; 2022 Jun; 32(6S1):6S26-6S32. PubMed ID: 36719643
[TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: The benefit of adopting Microultrasound in the prostate cancer imaging pathway : A lesion-by-lesion analysis.
Martel P; Rakauskas A; Dagher J; La Rosa S; Meuwly JY; Roth B; Valerio M
Prog Urol; 2022 Mar; ():. PubMed ID: 35292179
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer.
Maffei D; Fasulo V; Avolio PP; Saitta C; Paciotti M; De Carne F; Colombo P; Pasini L; De Zorzi SZ; Saita A; Hurle R; Lazzeri M; Guazzoni GF; Casale P; Buffi NM; Lughezzani G
Prostate; 2023 Jun; 83(9):886-895. PubMed ID: 36960788
[TBL] [Abstract][Full Text] [Related]
4. The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysis.
Avolio PP; Lughezzani G; Paciotti M; Maffei D; Uleri A; Frego N; Hurle R; Lazzeri M; Saita A; Guazzoni G; Casale P; Buffi NM
Urol Oncol; 2021 Dec; 39(12):832.e1-832.e7. PubMed ID: 34183255
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study.
Lughezzani G; Maffei D; Saita A; Paciotti M; Diana P; Buffi NM; Colombo P; Elefante GM; Hurle R; Lazzeri M; Guazzoni G; Casale P
Eur Urol Focus; 2021 Sep; 7(5):1019-1026. PubMed ID: 33069624
[TBL] [Abstract][Full Text] [Related]
6. MRI-directed high-frequency (29MhZ) TRUS-guided biopsies: initial results of a single-center study.
Cornud F; Lefevre A; Flam T; Dumonceau O; Galiano M; Soyer P; Camparo P; Barral M
Eur Radiol; 2020 Sep; 30(9):4838-4846. PubMed ID: 32350662
[TBL] [Abstract][Full Text] [Related]
7. Post-MRI transrectal micro-ultrasonography of transition zone PI-RADS > 2 lesions for biopsy guidance.
Cornud F; Lefevre A; Camparo P; Barat M; Dumonceau O; Galiano M; Flam T; Soyer P; Barral M
Eur Radiol; 2022 Nov; 32(11):7504-7512. PubMed ID: 35451606
[TBL] [Abstract][Full Text] [Related]
8. Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer.
Klotz L; Andriole G; Cash H; Cooperberg M; Crawford ED; Emberton M; Gomez-Sancha F; Klein E; Lughezzani G; Marks L; Montorsi F; Salomon G; Sanchez-Salas R; Shore N; Taneja S
Contemp Clin Trials; 2022 Jan; 112():106618. PubMed ID: 34728381
[TBL] [Abstract][Full Text] [Related]
9. Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study.
Rakauskas A; Peters M; Martel P; van Rossum PSN; La Rosa S; Meuwly JY; Roth B; Valerio M
PLoS One; 2023; 18(1):e0280262. PubMed ID: 36652429
[TBL] [Abstract][Full Text] [Related]
10. Detection of Clinically Significant Index Prostate Cancer Using Micro-ultrasound: Correlation With Radical Prostatectomy.
Callejas MF; Klein EA; Truong M; Thomas L; McKenney JK; Ghai S
Urology; 2022 Nov; 169():150-155. PubMed ID: 35843353
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Targeted Prostate Biopsy by Adding Micro-Ultrasound to the Magnetic Resonance Imaging Pathway.
Wiemer L; Hollenbach M; Heckmann R; Kittner B; Plage H; Reimann M; Asbach P; Friedersdorff F; Schlomm T; Hofbauer S; Cash H
Eur Urol Focus; 2021 Nov; 7(6):1292-1299. PubMed ID: 32654967
[TBL] [Abstract][Full Text] [Related]
12. MRI-TRUS fusion biopsy of the prostate: Quality of image fusion in a clinical setting.
Schlenker B; Apfelbeck M; Buchner A; Stief C; Clevert DA
Clin Hemorheol Microcirc; 2018; 70(4):433-440. PubMed ID: 30347605
[TBL] [Abstract][Full Text] [Related]
13. Detection of clinically significant prostate cancer by micro-ultrasound-informed systematic biopsy during MRI/micro-ultrasound fusion biopsy.
Wang B; Broomfield S; Martín AM; Albers P; Fung C; Kinnaird A
Can Urol Assoc J; 2023 Apr; 17(4):117-120. PubMed ID: 36486174
[TBL] [Abstract][Full Text] [Related]
14. Robotically controlled three-dimensional micro-ultrasound for prostate biopsy guidance.
Vassallo R; Aleef TA; Zeng Q; Wodlinger B; Black PC; Salcudean SE
Int J Comput Assist Radiol Surg; 2023 Jun; 18(6):1093-1099. PubMed ID: 36995513
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
[TBL] [Abstract][Full Text] [Related]
16. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
[TBL] [Abstract][Full Text] [Related]
17. The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy.
Perrin A; Venderink W; Patak MA; Möckel C; Fehr JL; Jichlinski P; Porcellini B; Lucca I; Futterer J; Valerio M
Urol Oncol; 2021 May; 39(5):297.e9-297.e16. PubMed ID: 33341358
[TBL] [Abstract][Full Text] [Related]
18. How MRI is changing prostate cancer management: a focus on early detection and active surveillance: Comment l'IRM est en train de révolutionner la prise en charge du cancer de la prostate : focus sur la détection précoce et la surveillance active.
Fiard G; Giganti F
Prog Urol; 2022 Jun; 32(6S1):6S19-6S25. PubMed ID: 36719642
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging-Targeted Biopsy and Pretherapeutic Prostate Cancer Risk Assessment: a Systematic Review: Biopsie ciblée par Imagerie par résonance magnétique et évaluation pré-thérapeutique du risque de cancer de la prostate : revue systématique.
Diamand R; Mjaess G; Ploussard G; Fiard G; Oderda M; Lefebvre Y; Sirtaine N; Roumeguère T; Peltier A; Albisinni S
Prog Urol; 2022 Jun; 32(6S1):6S3-6S18. PubMed ID: 36719644
[TBL] [Abstract][Full Text] [Related]
20. Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.
Washino S; Kobayashi S; Okochi T; Kameda T; Konoshi T; Miyagawa T; Takayama T; Morita T
BMC Urol; 2018 May; 18(1):51. PubMed ID: 29843694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]